Stockholm3试验在美国多族裔队列中应用可行性的族裔差异研究
本研究通过倾向性评分匹配,将芝加哥504名接受前列腺活检的男性与斯德哥尔摩6980名男性进行族裔特异性比较。非洲裔美国男性GG≥2前列腺癌检出率51%,匹配的斯德哥尔摩男性为34%(OR 2.1,p<0.001);非西班牙裔白人和西班牙裔白人匹配组间无统计学差异。Stockholm3在匹配的斯德哥尔摩队列中AUC分别为0.85、0.89、0.90,提示该工具可能需针对非洲裔美国男性重新校准。
要点
- 非洲裔美国男性GG≥2前列腺癌检出风险高于风险匹配的斯德哥尔摩男性。
- Stockholm3在匹配的斯德哥尔摩队列中对三个族裔亚组的AUC均较高。
- 研究提示Stockholm3用于多族裔美国人群前可能需针对非洲裔美国男性重新校准。
核心结论
- 模拟多族裔芝加哥队列发现非洲裔美国男性GG≥2前列腺癌风险 excess。
- Stockholm3在多族裔队列中可能具有良好预测价值,但至少非洲裔美国男性可能需重新校准。
研究设计与样本
- 回顾性可行性研究,纳入UIC 2016–2019年49–70岁接受前列腺活检的504名男性。
- 对照STHLM3研究2012–2014年6980名斯德哥尔摩男性。
- 采用倾向性评分匹配(年龄、PSA、前列腺体积、家族史、5α还原酶抑制剂使用、既往活检),按3:1匹配斯德哥尔摩与芝加哥族裔特异性队列。
主要发现
- 非洲裔美国男性GG≥2前列腺癌检出率51%,匹配的斯德哥尔摩男性为34%(OR 2.1,p<0.001)。
- 非西班牙裔白人匹配组检出率31% vs 24%(OR 0.7,p=0.30),无统计学差异。
- 西班牙裔白人匹配组检出率31% vs 27%(OR 1.2,p=0.42),无统计学差异。
- Stockholm3在匹配的斯德哥尔摩队列中对非洲裔美国、非西班牙裔白人、西班牙裔白人的AUC分别为0.85、0.89、0.90。
临床怎么用
- Stockholm3可用于多族裔美国人群的前列腺癌风险预测,但非洲裔美国男性需警惕校准偏差。
- 临床解读Stockholm3结果时应考虑族裔背景,非洲裔美国男性可能需要重新校准的预测模型。
局限性
- 为可行性研究,采用统计模拟而非直接在美国多族裔队列中验证Stockholm3。
- 样本量有限(芝加哥504名男性),结论需更大规模前瞻性研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Stockholm3 test improves Gleason Grade Group ≥2 (GG ≥ 2) prostate cancer (PC) detection, however it has not been evaluated in an American cohort where clinical practice patterns and ethnicity differ. We aimed to identify subgroups within a Stockholm population with PC risk profiles matching American ethnicity-specific subgroups and compare the detection of PC and describe Stockholm3 performance within these subgroups. METHODS: All men age 49-70 years presenting for prostate biopsies were evaluated at UIC from 2016 to 2019, as well as men in Stockholm from 2012 to 2014 in the STHLM3 study. Propensity scores (PS) were estimated for each person using logistic regression for age, PSA, prostate volume, family history of PC, 5-alpha reductase inhibitor use, and prior biopsy. 3:1 PS matching was performed for Stockholm to Chicago ethnicity-specific cohorts and odds ratios (OR) were computed to compare detection of GG ≥ 2 PC between groups. RESULTS: 504 Chicago men and 6980 Stockholm men were included. In African American (AA) men, 51% had GG ≥ 2 PC detected, while in risk-matched Stockholm men, 34% had GG ≥ 2 PC detected (OR: 2.1, p < 0.001). There was no statistical difference in GG ≥ 2 PC detected when matching Stockholm men to non-Hispanic Caucasian men (31% vs. 24%, OR: 0.7, p = 0.30) or Hispanic Caucasian men (31% vs. 27%, OR: 1.2, p = 0.42). The AUC for the Stockholm3 test of the matched Stockholm cohorts for AA, non-Hispanic Caucasian, and Hispanic Caucasian men was 0.85, 0.89, and 0.90, respectively. CONCLUSIONS: Using statistical techniques to simulate a multi-ethnic Chicago cohort within the STHLM3 population, we found an excess risk of GG ≥ 2 PC among AA men. Our hypothesis that the Stockholm3 may have good predictive value in a multiethnic cohort is strengthened, and that recalibration to at least AA men seems likely to be needed to obtain well-calibrated predictions.
引用
- Vigneswaran HT, Discacciati A, Gann PH, et al. Ethnic variation in prostate cancer detection: a feasibility study for use of the Stockholm3 test in a multiethnic U.S. cohort. Prostate Cancer Prostatic Dis. 2020. PMID: 32641739. doi:10.1038/s41391-020-0250-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。